EXEL

Exelixis Inc
Data: 2026-08-03

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Quick Stats
Aug 03, 2026

47.2

AI Score

HOLD

1.59

Volume Ratio

Aug 05, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

EXEL Stock Summary

Last updated Aug 03, 2026

EXEL is currently trading at $55.06, positioned above its 200-day moving average of $45.87, indicating a long-term uptrend. The stock has a 52-week range of $33.755 to $57.57.

Technical Analysis: The 50-day moving average stands at $53.67, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 51.0, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.126, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates EXEL at 47.2/100 with a HOLD recommendation.

EXEL (Exelixis Inc) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 51.0
CMF (20) 0.126
ROC (10) -0.846
ADX (14) 23.579
Indicator Value
MACD (12,26,9) 0.366
AROONOSC (14) -28.571
WILLAMS %R (14) -39.581
MFI (14) 47.535
EXEL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

EXEL Price vs Max Options Open Interest
EXEL Max Change In Options Open Interest

EXEL Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

EXEL Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

EXEL Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

EXEL Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Exelixis Inc is above both the 50 Day and 200 Day SMA which is considered Bullish.

EXEL Moving Averages Analysis

Exelixis Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 03, 2026

Exelixis Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 03, 2026

EXEL (Exelixis Inc) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 55.38
20 55.76
30 55.09
50 53.67
100 49.24
200 45.87

EXEL Fundamental Analysis

P/E (Forward) 16.7785
P/E (Trailing) 17.5596
Market Cap ($) 13.3 billion
Earnings/Share ($) 3.02
Net Profit Margin (%) 0.3508
Dividend/Share ($) --
EPS Estimate Current Year ($) 3.5355
EPS Estimate Next Year ($) 4.0493
WallStreet Target Price ($) 52.07
Most Recent Quarter